Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.64 |
| ▸ | TUBB1 | Q9H4B7 | 13/20 | 0.62 |
| ▸ | TUBB4A | P04350 | 8/20 | 0.62 |
| ▸ | TUBB | P07437 | 8/20 | 0.62 |
| ▸ | TUBA3C | P0DPH7 | 8/20 | 0.62 |
| ▸ | TUBA1B | P68363 | 8/20 | 0.62 |
| ▸ | TUBA4A | P68366 | 8/20 | 0.62 |
| ▸ | TUBB4B | P68371 | 8/20 | 0.62 |
| ▸ | TUBB3 | Q13509 | 8/20 | 0.62 |
| ▸ | TUBB2A | Q13885 | 8/20 | 0.62 |
| ▸ | TUBB8 | Q3ZCM7 | 8/20 | 0.62 |
| ▸ | TUBA3E | Q6PEY2 | 8/20 | 0.62 |
| ▸ | TUBA1A | Q71U36 | 8/20 | 0.62 |
| ▸ | TUBA1C | Q9BQE3 | 8/20 | 0.62 |
| ▸ | TUBB6 | Q9BUF5 | 8/20 | 0.62 |
| ▸ | TUBB2B | Q9BVA1 | 8/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8350155 | 1.00 | CYP1A1 (0.64) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL68067 | 1.00 | CYP1A1 (0.64) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL4608533 | 0.88 | CYP1A1 (0.79) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL4608535 | 0.88 | CYP1A1 (0.79) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL7193661 | 0.88 | TUBB1 (0.59) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL28707675 | 0.87 | TUBB1 (0.62) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL2622571 | 0.84 | CYP1A1 (0.67) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL28721891 | 0.83 | ALDH1A1 (0.47) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL19415560 | 0.83 | TUBB1 (0.53) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A | |
| SCHEMBL29582562 | 0.83 | ALDH1A1 (0.47) | CYP1A1CYP1A2CYP1B1TUBB1TUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4209542-A | Process for augmenting or enhancing the aroma or taste of a foodstuff by adding to a foodstuff a mixture of 1-acyl-2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-06-24 | — | — | US | claimed |
| US-4103036-A | Flavoring with derivatives of 1-acetyl-3,3-dimethylcyclohexane, and processes for using same and processes for preparing said 1-acetyl-3,3-dimethylcyclohexane derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-07-25 | — | — | US | claimed |
| US-4084009-A | 4-HYDROXY-2,4,6,6-TETRAMETHYLCYCLOHEX-2-ENE-1-ONE, ORGANOLEPTIC | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-04-11 | — | — | US | claimed |
| US-4076854-A | ADJUVANTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-02-28 | — | — | US | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-4126140-A | Smoking tobacco and smoking tobacco flavoring compositions containing hydroxy cyclohexenone derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-11-21 | — | — | US | disclosed |
| US-4122120-A | ISOMERIZATION OF A PROPARGYL ALCOHOL | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-10-24 | — | — | US | disclosed |
| US-4119574-A | 4-Hydroxy-2,4,6,6-tetramethyl cyclohex-2-en-1-one perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-10-10 | — | — | US | disclosed |
| US-4107093-A | 3,3-Dimethyl-1-(4-methylvaleryl)-cyclohexane perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-08-15 | — | — | US | disclosed |
| US-4103036-A | Flavoring with derivatives of 1-acetyl-3,3-dimethylcyclohexane, and processes for using same and processes for preparing said 1-acetyl-3,3-dimethylcyclohexane derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4084009-A | 4-HYDROXY-2,4,6,6-TETRAMETHYLCYCLOHEX-2-ENE-1-ONE, ORGANOLEPTIC | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-04-11 | — | — | US | disclosed |
| US-4076854-A | ADJUVANTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-02-28 | — | — | US | disclosed |
| US-4062894-A | AROMA, ODORANTS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | CYP1A1 228/4885CYP1A2 107/4885CYP1B1 138/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | CYP1A1 2153/4885CYP1A2 1841/4885CYP1B1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.